by admin | Oct 28, 2021 | News
By: Robyn Woidtke, MSN, RN, RPSGT, CCSH, FAAST Non-adherence in patients with obstructive sleep apnea (OSA) is a known risk factor which may contribute to worsening of the condition, exacerbate co-morbid or multimorbid conditions or contribute to the development of...
by admin | Sep 24, 2021 | News
By: Sam Kashani, MD, FAASM In August 2021, Jazz Pharmaceuticals announced the US FDA approval of Xywav for the treatment of idiopathic hypersomnia in adults. Xywav, an oral solution consisting primarily of oxybate (GHB), already has approval for the treatment of...
by admin | Aug 13, 2021 | News
By: Andrew Binder, MD, FAASM, FCCP I love being a sleep doctor. I often introduce myself as a “recovering pulmonary and critical care doctor.” One of the reasons I love being a sleep doctor is that I think it is one of the few things, in my advanced age, at which I...
by admin | Jul 31, 2021 | News
By: Said Mostafavi, MD, FCCP, FAASM Like most sleep physicians, treating sleep-disordered breathing constitutes a large percentage of my practice. When it comes to treating obstructive sleep apnea, we thankfully have various treatment options available, some...
by admin | Jun 21, 2021 | News
By: By Patrick Moday, BBA, RPSGT, RST, CCSH I started working in sleep clinical research while in college and would attend pharmaceutical conferences every 3-4 months. The meetings were about pharmaceutical medications for sleep-related conditions. There were cool...
by admin | May 13, 2021 | News
By: Robyn Woidtke, RN, RPSGT Why should we care about and recognize polycystic ovarian syndrome (PCOS) in sleep health? This “very” brief overview is aimed to answer some of those questions. Additionally, an objective would be to create an interest in reaching out...
